ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
SPDR S&P Biotech ETF
122.40
-2.9450
-2.35%
成交量:
348.37万
成交额:
4.27亿
市值:
77.60亿
市盈率:
6.71
高:
125.37
开:
125.28
低:
121.69
收:
125.34
52周最高:
132.09
52周最低:
66.66
股本:
6,340.00万
流通股本:
6,340.00万
量比:
1.17
换手率:
5.49%
股息:
0.45
股息率:
0.37%
每股收益(TTM):
18.23
净资产收益率:
--
总资产收益率:
--
市净率:
--
市盈率(LYR):
- -
数据加载中...
总览
公司
新闻资讯
公告
概念
高盛持仓
-0.31%
ETF&股票定投概念
-0.10%
碎股
-0.10%
资金流向
资金流入:
资金流出:
实时
日
周
月
季度
年
新闻资讯
Humana公布季度亏损扩大,预计2026年盈利将下降
环球市场播报
·
昨天
Healthcare Services第四季度EPS为0.44美元 高于预期
格隆汇
·
昨天
和谐健康保险泰安中支被罚16万,涉编制虚假资料
蓝鲸财经
·
昨天
医疗保健板块动态:市场快讯解读
投资观察
·
昨天
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/XBI"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"SPDR S&P Biotech ETF","latestPrice":122.395,"timestamp":1770827570920,"preClose":125.34,"halted":0,"volume":3483662,"delay":0,"changeRate":-0.023496090633477,"floatShares":63400000,"shares":63400000,"eps":18.23,"marketStatus":"交易中","change":-2.945,"latestTime":"02-11 11:32:52 EST","open":125.275,"high":125.365,"low":121.69,"amount":427460028.45364004,"amplitude":0.02932,"askPrice":122.4,"askSize":47,"bidPrice":122.38,"bidSize":173,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1770843600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":125.34,"sharesOutstanding":64100000,"nav":126.072264,"aum":8081232115.54,"dividendRate":0.003686,"bidAskSpread":0.000212,"preHourTrading":{"tag":"盘前","latestPrice":125.31,"preClose":125.34,"latestTime":"09:29 EST","volume":31777,"amount":3985268.60274,"timestamp":1770820199999,"change":-0.03,"changeRate":-0.000239,"amplitude":0.008846},"postHourTrading":{"tag":"盘后","latestPrice":125.39,"preClose":125.34,"latestTime":"19:58 EST","volume":832189,"amount":104303705.3068,"timestamp":1770771513071,"change":0.05,"changeRate":0.000399,"amplitude":0.003191},"volumeRatio":1.168647,"impliedVol":0.3083,"impliedVolPercentile":0.5936},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":63400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.168647,"shares":63400000,"dividePrice":0.4512,"high":125.365,"amplitude":0.02932,"preClose":125.34,"low":121.69,"week52Low":66.66,"pbRate":"--","week52High":132.09,"institutionHeld":0.8511,"latestPrice":122.395,"committee":0.572727,"eps":18.23,"divideRate":0.003686,"volume":3483662,"delay":0,"ttmEps":18.23,"open":125.275,"prevYearClose":121.93,"prevWeekClose":125.51,"prevMonthClose":124.75,"prevQuarterClose":121.93,"fiveDayClose":125.29,"twentyDayClose":123.85,"sixtyDayClose":111.91},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"},{"date":"2024-12-23","symbol":"XBI","amount":0.002687,"announcedDate":"2024-12-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-26","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-03-18","recordDate":"2016-03-22","paymentDate":"2016-03-29","value":0.057833,"currency":"USD"},{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-06-27","value":0.045491,"currency":"USD"},{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610955288","title":"Humana公布季度亏损扩大,预计2026年盈利将下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2610955288","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610955288?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 22:29","pubTimestamp":1770820140,"startTime":"0","endTime":"0","summary":"Humana公司公布第四季度亏损扩大,原因是医疗成本持续上升,并表示由于其联邦医疗保险计划的质量评级下降,预计 2026 年盈利将大幅下滑。 该公司报告亏损 10.1 亿美元,合每股亏损 6.61 美元;去年同期亏损 8.62 亿美元,合每股亏损 5.76 美元。 Humana预计,2026 年个人联邦医疗保险优选计划会员数量将增长约 25%,“这得益于公司以客户为导向的福利策略带来的新增销售与留存率提升,以及客户服务模式的优化”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-11/doc-inhmnhqz7462659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LABU","BK4585","BK4588","XBI","BK4581","XLV"],"gpt_icon":0},{"id":"2610934545","title":"Healthcare Services第四季度EPS为0.44美元 高于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2610934545","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610934545?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 20:01","pubTimestamp":1770811298,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","LABU","XLV","BK4588","BK4581","XBI","HCAR"],"gpt_icon":0},{"id":"2610933683","title":"和谐健康保险泰安中支被罚16万,涉编制虚假资料","url":"https://stock-news.laohu8.com/highlight/detail?id=2610933683","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610933683?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 17:54","pubTimestamp":1770803676,"startTime":"0","endTime":"0","summary":"蓝鲸新闻2月11日讯,近日,国家金融监督管理总局泰安监管分局发布了罚单,剑指和谐健康保险股份有限公司泰安中心支公司及其时任经理陈传美。罚单显示,和谐健康保险股份有限公司泰安中心支公司的主要违法违规事实为:编制虚假资料。针对这一行为,国家金融监督管理总局泰安监管分局对其罚款16万元;对时任和谐健康保险股份有限公司泰安中心支公司营业部经理陈传美,警告并处以1.5万元罚款。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1770801258420902225","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["LABU","BK4588","BK4585","BK4581","XLV","XBI"],"gpt_icon":0},{"id":"1186140440","title":"医疗保健板块动态:市场快讯解读","url":"https://stock-news.laohu8.com/highlight/detail?id=1186140440","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186140440?lang=zh_cn&edition=fundamental","pubTime":"2026-02-11 17:23","pubTimestamp":1770801827,"startTime":"0","endTime":"0","summary":"0241 GMT——尽管哈塔勒加集团在第三财季业绩超预期,但其销售增长动能仍显不足,联昌国际证券分析师陈成荣在研究报告中指出。他表示,手套供应过剩局面预计将至少持续至2027年,供需才能重新平衡。陈成荣将哈塔勒加2026至2028财年的核心净利润预测分别上调126%、70%和41%,主要基于成本假设的下调。联昌国际将其目标价从1.18林吉特下调至1.00林吉特,维持持有评级。该股当前上涨2.2%,报0.94林吉特。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XBI","BK4581","BK4585","BK4588","XLV"],"gpt_icon":0}],"pageSize":4,"totalPage":35,"pageCount":1,"totalSize":138,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/XBI\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"高盛持仓","bkCode":"BK4581","id":"package_us_concept_gscc","changeRate":-0.003056},{"market":"US","name":"ETF&股票定投概念","bkCode":"BK4585","id":"package_us_concept_etf&gpdt","changeRate":-0.000994},{"market":"US","name":"碎股","bkCode":"BK4588","id":"package_us_concept_sg","changeRate":-0.000995}]}}